NIOX MINO®

DEVICE2 trials

Sponsors

Aerocrine AB, Wake Forest University

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Unknown Phase

Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms

CompletedNCT01518322

Aerocrine ABAsthma

Start: 2011-11-30End: 2012-02-29Updated: 2013-08-30

Evaluation of FeNO During and Following Acute COPD Exacerbation

TerminatedNCT01761006

Wake Forest UniversityChronic Obstructive Pulmonary Disease

Start: 2013-03-31End: 2014-09-23Updated: 2017-11-07